Search PubMed⌕ Search

Biomedical subjects

S Karube

Publications and source records attributed to S Karube.

26 records · Page 2Linked to original sources

Compositional changes of glycosaminoglycans of the human menisci with age and degenerative joint disease.

The compositional profiles of meniscal glycosaminoglycans (GAG) at different ages and in the presence of osteoarthritis were determined. The major components of meniscal GAG were chondroitin sulphates and dermatan sulphate. Other major elements were keratan sulphate and hyaluronic acid. Chondroitin sulphate-4 and -6 decreased with age. Dermatan sulphate content remained unchanged with age whereas keratan sulphate and hyaluronic acid increased. GAG compositional profiles of meniscus from osteoarthritis were similar to those of comparable age group. The results indicate that GAG compositional make-up of the meniscus changes with age. These changes may make it more susceptible to horizontal tears in the elderly.

Adolescent↗

[Biochemical study of human articular cartilage and meniscus on aging and joint disease (author's transl)].

We studied biochemically the changes associated with aging and disease in the collagen of articular cartilages and menisci. Pepsin soluble and insoluble collagen were obtained by the method of Miller (1971) from the articular cartilages of seven healthy young and adult, six healthy aged subjects, and of six osteoarthritic and six rheumatoid arthritic patients. One portion of pathological cartilage was histologically examined to eliminate any possible contamination of the fibrous tissue and subchondral bone, and to classify the pathological findings. By the method of Miller, the pepsin soluble and insoluble collagen were also obtained from four adult and six aged menisci. Amino acid composition and carbohydrate contents were studied in insoluble collagen. The type of soluble collagen were analyzed with SDS disc electrophoresis. The amount of crosslinks in insoluble collagen was analyzed by the method of Masuda (1976) using automatic amino acid analyzer. The results obtained where shown as follow: 1) Solubility of collagen by pepsin decreased with aging on articular cartilages and menisci. In osteoarthritis and rheumatoid arthritis, the solubility of collagen by pepsin was different between the samples, and generally higher than that of collagen from the aged articular cartilages. 2) In respect to aldimine crosslinks of insoluble collagen, the dihydroxylysinonorleucine (DHLNL), hydroxylysinonorleucine (HLNL) and lysinonorleucine (LNL) increased with aging. DHLNL and HLNL were present in the nonreduced collagen in vitro. It was shown that the aldimine crosslinks had been already reduced in vivo. 3) The contents of carbohydrate of insoluble collagen from articular cartilage showed lower values than that of type II collagen as described previously. The hexosamine contents increased and those of uronic acid and hexose decreased with aging. In osteoarthritic and rheumatoid arthritic articular cartilages, the contents of uronic acid were lower than that of healthy aged group. The carbohydrate contents of menisci were similar to that of type I collagen. 4) concerning the type of collagen, healthy articular cartilages consisted of type II collagen. In collagen of aged cartilages and those of fibrillated and osteophytic cartilages in osteoarthritic and rheumatoid arthritic patients, the type II collagen were mixed with type I collagen ranging from 13.8% to 64.5%, although the analysis of articular cartilages in this study showed histological characteristics of hyaline cartilage. The type of soluble collagen in adult and aged menisci were composed of type I collagen in spite of aging.

Adolescent↗

[Comparison of treatments in senile osteoporosis: follow up for 12 months (author's transl)].

We randomly divided senile osteoporotic patients into 8 groups. Eleven patients of A-Group were treated daily with 900 mg of calcium and 50 mg of sodium fluoride and 50,000 units of vitamin D twice weekly. Fourteen patients of B-Group were treated daily with 900 mg of calcium and 50 mg of sodium fluoride. Twelve patients of C-Group were treated daily with 50 mg of sodium fluoride. Ten patients of D-Group were treated daily with 900 mg of calcium, 50 mg of sodium fluoride and 2 mg of estriol. Ten patients of E-Group were treated daily with 2 mg of estriol. Ten patients of F-Group were treated daily with 900 mg of calcium. Ten patients of G-Group were treated daily with 900 mg of calcium and 2 mg of estriol. The treatments were given for 12 months. Ten patients without treatment served as the non-treated control group. In each group, mineral contents were measured with Norland Bone Mineral Analyzer at the level of the distal third of the left radius and ulna before and after treatment. Mineral contents of ulnar bone in A-Group, of radial and ulnar bones in E-Group, F-Group, and G-Group increased with statistical significance after 12 months of the therapy. Mineral contents of radial and ulnar bones in C-Group and Nontreated Group decreased with statistical significance after 12 months. In laboratory examination, we observed no severe side-effect in our patients. But it was very interesting that the values of serum alkaline phosphatase in F-Group and G-Group decreased with statistical significance after 12 months of the therapies.

Aged↗